Catalyst Wire Dossier Catalyst Wire Dossier

Bifidobacterium animalis subsp. lactis Bi66

Bifidobacterium animalis subsp. lactis Bi66
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bifidobacterium animalis subsp. lactis Bi66, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Bifidobacterium Animalis Subsp. Lactis Bi66 Supplementation on Gut Function in Healthy Adults [NA]

See pricing